Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients

Children with cystic fibrosis (CF) often take proton pump inhibitors (PPIs), which helps improve efficacy of fat absorption with pancreatic enzyme replacement therapy. However, PPI use is known to be associated with Clostridium difficile-(C. diff-) associated diarrhea (CDAD). We retrospectively eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Pohl, John F., Patel, Raza, Zobell, Jeffery T., Lin, Ellen, Korgenski, E. Kent, Crowell, Kody, MacKay, Mark W., Richman, Aleesha, Larsen, Christian, Chatfield, Barbara A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226314/
https://www.ncbi.nlm.nih.gov/pubmed/22144994
http://dx.doi.org/10.1155/2011/345012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226314/
https://www.ncbi.nlm.nih.gov/pubmed/22144994
http://dx.doi.org/10.1155/2011/345012

Ejemplares similares